Global Diabetic Neurological Disorder Therapeutic Drug Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Diabetic Neurological Disorder Therapeutic Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Diabetic Neurological Disorder Therapeutic Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Diabetic Neurological Disorder Therapeutic Drug market. Diabetic Neurological Disorder Therapeutic Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Diabetic Neurological Disorder Therapeutic Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Diabetic Neurological Disorder Therapeutic Drug market.
A drug used to treat mental illness caused by diabetes
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Diabetic Neurological Disorder Therapeutic Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Diabetic Neurological Disorder Therapeutic Drug market. It may include historical data, market segmentation by Type (e.g., Capsule, Pills), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Diabetic Neurological Disorder Therapeutic Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Diabetic Neurological Disorder Therapeutic Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Diabetic Neurological Disorder Therapeutic Drug industry. This include advancements in Diabetic Neurological Disorder Therapeutic Drug technology, Diabetic Neurological Disorder Therapeutic Drug new entrants, Diabetic Neurological Disorder Therapeutic Drug new investment, and other innovations that are shaping the future of Diabetic Neurological Disorder Therapeutic Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Diabetic Neurological Disorder Therapeutic Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Diabetic Neurological Disorder Therapeutic Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Diabetic Neurological Disorder Therapeutic Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Diabetic Neurological Disorder Therapeutic Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Diabetic Neurological Disorder Therapeutic Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Diabetic Neurological Disorder Therapeutic Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Diabetic Neurological Disorder Therapeutic Drug market.
Market Segmentation:
Diabetic Neurological Disorder Therapeutic Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Diabetic Neurological Disorder Therapeutic Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Diabetic Neurological Disorder Therapeutic Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Diabetic Neurological Disorder Therapeutic Drug market. Diabetic Neurological Disorder Therapeutic Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Diabetic Neurological Disorder Therapeutic Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Diabetic Neurological Disorder Therapeutic Drug market.
A drug used to treat mental illness caused by diabetes
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Diabetic Neurological Disorder Therapeutic Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Diabetic Neurological Disorder Therapeutic Drug market. It may include historical data, market segmentation by Type (e.g., Capsule, Pills), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Diabetic Neurological Disorder Therapeutic Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Diabetic Neurological Disorder Therapeutic Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Diabetic Neurological Disorder Therapeutic Drug industry. This include advancements in Diabetic Neurological Disorder Therapeutic Drug technology, Diabetic Neurological Disorder Therapeutic Drug new entrants, Diabetic Neurological Disorder Therapeutic Drug new investment, and other innovations that are shaping the future of Diabetic Neurological Disorder Therapeutic Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Diabetic Neurological Disorder Therapeutic Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Diabetic Neurological Disorder Therapeutic Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Diabetic Neurological Disorder Therapeutic Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Diabetic Neurological Disorder Therapeutic Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Diabetic Neurological Disorder Therapeutic Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Diabetic Neurological Disorder Therapeutic Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Diabetic Neurological Disorder Therapeutic Drug market.
Market Segmentation:
Diabetic Neurological Disorder Therapeutic Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Capsule
- Pills
- Other
- Symmetrical Neuropathy
- Focal and Multifocal Neuropathy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Johnson & Johnson
- Takeda
- Mitsubishi Chemical
- Avanir Pharmaceuticals
- Dong-A Pharmaceutical Co., Ltd.
- Immune Pharmaceuticals
- MediciNova
- Sangamo BioSciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2030
2.1.2 Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Diabetic Neurological Disorder Therapeutic Drug Segment by Type
2.2.1 Capsule
2.2.2 Pills
2.2.3 Other
2.3 Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
2.3.1 Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
2.4 Diabetic Neurological Disorder Therapeutic Drug Segment by Application
2.4.1 Symmetrical Neuropathy
2.4.2 Focal and Multifocal Neuropathy
2.5 Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
2.5.1 Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
3 DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG MARKET SIZE BY PLAYER
3.1 Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Players
3.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024)
3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG BY REGIONS
4.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions (2019-2024)
4.2 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
4.3 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
4.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)
5.2 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
5.3 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024)
6.2 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
6.3 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Diabetic Neurological Disorder Therapeutic Drug by Country (2019-2024)
7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug by Region (2019-2024)
8.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG MARKET FORECAST
10.1 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Regions (2025-2030)
10.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Regions (2025-2030)
10.1.2 Americas Diabetic Neurological Disorder Therapeutic Drug Forecast
10.1.3 APAC Diabetic Neurological Disorder Therapeutic Drug Forecast
10.1.4 Europe Diabetic Neurological Disorder Therapeutic Drug Forecast
10.1.5 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Forecast
10.2 Americas Diabetic Neurological Disorder Therapeutic Drug Forecast by Country (2025-2030)
10.2.1 United States Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.2.2 Canada Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.2.3 Mexico Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.2.4 Brazil Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3 APAC Diabetic Neurological Disorder Therapeutic Drug Forecast by Region (2025-2030)
10.3.1 China Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.2 Japan Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.3 Korea Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.4 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.5 India Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.6 Australia Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4 Europe Diabetic Neurological Disorder Therapeutic Drug Forecast by Country (2025-2030)
10.4.1 Germany Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.2 France Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.3 UK Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.4 Italy Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.5 Russia Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Forecast by Region (2025-2030)
10.5.1 Egypt Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.2 South Africa Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.3 Israel Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.4 Turkey Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.5 GCC Countries Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.6 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Type (2025-2030)
10.7 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Mitsubishi Chemical
11.4.1 Mitsubishi Chemical Company Information
11.4.2 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mitsubishi Chemical Main Business Overview
11.4.5 Mitsubishi Chemical Latest Developments
11.5 Avanir Pharmaceuticals
11.5.1 Avanir Pharmaceuticals Company Information
11.5.2 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Avanir Pharmaceuticals Main Business Overview
11.5.5 Avanir Pharmaceuticals Latest Developments
11.6 Dong-A Pharmaceutical Co., Ltd.
11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Information
11.6.2 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dong-A Pharmaceutical Co., Ltd. Main Business Overview
11.6.5 Dong-A Pharmaceutical Co., Ltd. Latest Developments
11.7 Immune Pharmaceuticals
11.7.1 Immune Pharmaceuticals Company Information
11.7.2 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Immune Pharmaceuticals Main Business Overview
11.7.5 Immune Pharmaceuticals Latest Developments
11.8 MediciNova
11.8.1 MediciNova Company Information
11.8.2 MediciNova Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 MediciNova Main Business Overview
11.8.5 MediciNova Latest Developments
11.9 Sangamo BioSciences
11.9.1 Sangamo BioSciences Company Information
11.9.2 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sangamo BioSciences Main Business Overview
11.9.5 Sangamo BioSciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2030
2.1.2 Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Diabetic Neurological Disorder Therapeutic Drug Segment by Type
2.2.1 Capsule
2.2.2 Pills
2.2.3 Other
2.3 Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
2.3.1 Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
2.4 Diabetic Neurological Disorder Therapeutic Drug Segment by Application
2.4.1 Symmetrical Neuropathy
2.4.2 Focal and Multifocal Neuropathy
2.5 Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
2.5.1 Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
3 DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG MARKET SIZE BY PLAYER
3.1 Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Players
3.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024)
3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG BY REGIONS
4.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions (2019-2024)
4.2 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
4.3 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
4.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
4.5 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)
5.2 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
5.3 Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024)
6.2 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
6.3 APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Diabetic Neurological Disorder Therapeutic Drug by Country (2019-2024)
7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug by Region (2019-2024)
8.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG MARKET FORECAST
10.1 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Regions (2025-2030)
10.1.1 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Regions (2025-2030)
10.1.2 Americas Diabetic Neurological Disorder Therapeutic Drug Forecast
10.1.3 APAC Diabetic Neurological Disorder Therapeutic Drug Forecast
10.1.4 Europe Diabetic Neurological Disorder Therapeutic Drug Forecast
10.1.5 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Forecast
10.2 Americas Diabetic Neurological Disorder Therapeutic Drug Forecast by Country (2025-2030)
10.2.1 United States Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.2.2 Canada Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.2.3 Mexico Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.2.4 Brazil Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3 APAC Diabetic Neurological Disorder Therapeutic Drug Forecast by Region (2025-2030)
10.3.1 China Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.2 Japan Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.3 Korea Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.4 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.5 India Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.3.6 Australia Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4 Europe Diabetic Neurological Disorder Therapeutic Drug Forecast by Country (2025-2030)
10.4.1 Germany Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.2 France Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.3 UK Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.4 Italy Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.4.5 Russia Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Forecast by Region (2025-2030)
10.5.1 Egypt Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.2 South Africa Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.3 Israel Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.4 Turkey Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.5.5 GCC Countries Diabetic Neurological Disorder Therapeutic Drug Market Forecast
10.6 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Type (2025-2030)
10.7 Global Diabetic Neurological Disorder Therapeutic Drug Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Mitsubishi Chemical
11.4.1 Mitsubishi Chemical Company Information
11.4.2 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mitsubishi Chemical Main Business Overview
11.4.5 Mitsubishi Chemical Latest Developments
11.5 Avanir Pharmaceuticals
11.5.1 Avanir Pharmaceuticals Company Information
11.5.2 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Avanir Pharmaceuticals Main Business Overview
11.5.5 Avanir Pharmaceuticals Latest Developments
11.6 Dong-A Pharmaceutical Co., Ltd.
11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Information
11.6.2 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Dong-A Pharmaceutical Co., Ltd. Main Business Overview
11.6.5 Dong-A Pharmaceutical Co., Ltd. Latest Developments
11.7 Immune Pharmaceuticals
11.7.1 Immune Pharmaceuticals Company Information
11.7.2 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Immune Pharmaceuticals Main Business Overview
11.7.5 Immune Pharmaceuticals Latest Developments
11.8 MediciNova
11.8.1 MediciNova Company Information
11.8.2 MediciNova Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 MediciNova Main Business Overview
11.8.5 MediciNova Latest Developments
11.9 Sangamo BioSciences
11.9.1 Sangamo BioSciences Company Information
11.9.2 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product Offered
11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sangamo BioSciences Main Business Overview
11.9.5 Sangamo BioSciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Capsule
Table 3. Major Players of Pills
Table 4. Major Players of Other
Table 5. Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 8. Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 11. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Player (2019-2024)
Table 13. Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Products Offered
Table 14. Diabetic Neurological Disorder Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Regions (2019-2024)
Table 19. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Country (2019-2024)
Table 23. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 25. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 27. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region (2019-2024)
Table 29. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 31. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 33. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Country (2019-2024)
Table 35. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 37. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Diabetic Neurological Disorder Therapeutic Drug
Table 46. Key Market Challenges & Risks of Diabetic Neurological Disorder Therapeutic Drug
Table 47. Key Industry Trends of Diabetic Neurological Disorder Therapeutic Drug
Table 48. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. AstraZeneca Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 53. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 54. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AstraZeneca Main Business
Table 56. AstraZeneca Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 58. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Johnson & Johnson Latest Developments
Table 62. Takeda Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 63. Takeda Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 64. Takeda Main Business
Table 65. Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Takeda Latest Developments
Table 67. Mitsubishi Chemical Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 68. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 69. Mitsubishi Chemical Main Business
Table 70. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Mitsubishi Chemical Latest Developments
Table 72. Avanir Pharmaceuticals Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 73. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 74. Avanir Pharmaceuticals Main Business
Table 75. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Avanir Pharmaceuticals Latest Developments
Table 77. Dong-A Pharmaceutical Co., Ltd. Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 78. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 79. Dong-A Pharmaceutical Co., Ltd. Main Business
Table 80. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Dong-A Pharmaceutical Co., Ltd. Latest Developments
Table 82. Immune Pharmaceuticals Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 83. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 84. Immune Pharmaceuticals Main Business
Table 85. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Immune Pharmaceuticals Latest Developments
Table 87. MediciNova Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 88. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 89. MediciNova Main Business
Table 90. MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. MediciNova Latest Developments
Table 92. Sangamo BioSciences Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 93. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 94. Sangamo BioSciences Main Business
Table 95. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Sangamo BioSciences Latest Developments
Table 1. Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Capsule
Table 3. Major Players of Pills
Table 4. Major Players of Other
Table 5. Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 8. Diabetic Neurological Disorder Therapeutic Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 11. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Player (2019-2024)
Table 13. Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Products Offered
Table 14. Diabetic Neurological Disorder Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Regions (2019-2024)
Table 19. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Country (2019-2024)
Table 23. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 25. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 27. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region (2019-2024)
Table 29. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 31. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 33. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Country (2019-2024)
Table 35. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 37. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Diabetic Neurological Disorder Therapeutic Drug
Table 46. Key Market Challenges & Risks of Diabetic Neurological Disorder Therapeutic Drug
Table 47. Key Industry Trends of Diabetic Neurological Disorder Therapeutic Drug
Table 48. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. AstraZeneca Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 53. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 54. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. AstraZeneca Main Business
Table 56. AstraZeneca Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 58. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Johnson & Johnson Latest Developments
Table 62. Takeda Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 63. Takeda Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 64. Takeda Main Business
Table 65. Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Takeda Latest Developments
Table 67. Mitsubishi Chemical Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 68. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 69. Mitsubishi Chemical Main Business
Table 70. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Mitsubishi Chemical Latest Developments
Table 72. Avanir Pharmaceuticals Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 73. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 74. Avanir Pharmaceuticals Main Business
Table 75. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Avanir Pharmaceuticals Latest Developments
Table 77. Dong-A Pharmaceutical Co., Ltd. Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 78. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 79. Dong-A Pharmaceutical Co., Ltd. Main Business
Table 80. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Dong-A Pharmaceutical Co., Ltd. Latest Developments
Table 82. Immune Pharmaceuticals Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 83. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 84. Immune Pharmaceuticals Main Business
Table 85. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Immune Pharmaceuticals Latest Developments
Table 87. MediciNova Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 88. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 89. MediciNova Main Business
Table 90. MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. MediciNova Latest Developments
Table 92. Sangamo BioSciences Details, Company Type, Diabetic Neurological Disorder Therapeutic Drug Area Served and Its Competitors
Table 93. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product Offered
Table 94. Sangamo BioSciences Main Business
Table 95. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Sangamo BioSciences Latest Developments
LIST OF FIGURES
Figure 1. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Diabetic Neurological Disorder Therapeutic Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Diabetic Neurological Disorder Therapeutic Drug Sales Market Share by Country/Region (2023)
Figure 8. Diabetic Neurological Disorder Therapeutic Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type in 2023
Figure 10. Diabetic Neurological Disorder Therapeutic Drug in Symmetrical Neuropathy
Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market: Symmetrical Neuropathy (2019-2024) & ($ Millions)
Figure 12. Diabetic Neurological Disorder Therapeutic Drug in Focal and Multifocal Neuropathy
Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market: Focal and Multifocal Neuropathy (2019-2024) & ($ Millions)
Figure 14. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application in 2023
Figure 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Player in 2023
Figure 16. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 18. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 19. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 21. Americas Diabetic Neurological Disorder Therapeutic Drug Value Market Share by Country in 2023
Figure 22. United States Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region in 2023
Figure 27. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type in 2023
Figure 28. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application in 2023
Figure 29. China Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Country in 2023
Figure 36. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Figure 37. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Figure 38. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 52. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 53. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 55. United States Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 56. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 59. China Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 60. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 61. Korea Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 63. India Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 64. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 65. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 66. France Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 67. UK Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 68. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 69. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 70. Spain Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 73. Israel Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 76. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Diabetic Neurological Disorder Therapeutic Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Diabetic Neurological Disorder Therapeutic Drug Sales Market Share by Country/Region (2023)
Figure 8. Diabetic Neurological Disorder Therapeutic Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type in 2023
Figure 10. Diabetic Neurological Disorder Therapeutic Drug in Symmetrical Neuropathy
Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market: Symmetrical Neuropathy (2019-2024) & ($ Millions)
Figure 12. Diabetic Neurological Disorder Therapeutic Drug in Focal and Multifocal Neuropathy
Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market: Focal and Multifocal Neuropathy (2019-2024) & ($ Millions)
Figure 14. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application in 2023
Figure 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Player in 2023
Figure 16. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 18. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 19. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size 2019-2024 ($ Millions)
Figure 21. Americas Diabetic Neurological Disorder Therapeutic Drug Value Market Share by Country in 2023
Figure 22. United States Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region in 2023
Figure 27. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type in 2023
Figure 28. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application in 2023
Figure 29. China Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Country in 2023
Figure 36. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Figure 37. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Figure 38. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Diabetic Neurological Disorder Therapeutic Drug Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 52. APAC Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 53. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 55. United States Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 56. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 59. China Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 60. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 61. Korea Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 63. India Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 64. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 65. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 66. France Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 67. UK Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 68. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 69. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 70. Spain Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 73. Israel Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Diabetic Neurological Disorder Therapeutic Drug Market Size 2025-2030 ($ Millions)
Figure 76. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share Forecast by Application (2025-2030)
